Clinical significance of circulating interleukin-23 as a prognostic factor in breast cancer patients

Dual Roles of Immune Cells and Their Factors in Cancer Development and Progression

(2012) Brian F. Zamarron et al.   International Journal of Biological Sciences

Role of interleukin-23 circulating levels increase in resected colorectal cancer before and after chemotherapy: Preliminary data and future perspectives

(2011) V. Adamo et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Regulation of Antitumor Immune Responses by the IL-12 Family Cytokines, IL-12, IL-23, and IL-27

(2010) Mingli Xu et al.   Clinical & Developmental Immunology

Proinflammatory Cytokines in Breast Cancer: Mechanisms of Action and Potential Targets for Therapeutics

(2010) Jodi E. Goldberg et al.   CURRENT DRUG TARGETS

Deconstructing the molecular portraits of breast cancer

(2010) Aleix Prat et al.   Molecular Oncology

The effects of trastuzumab on the CD4+CD25+FoxP3+ and CD4+IL17A+ T-cell axis in patients with breast cancer

(2009) C Horlock et al.   BRITISH JOURNAL OF CANCER

Cytokine mediators of Th17 function

(2009) Rosanne Spolski et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Regulation of interleukin-12/interleukin-23 production and the T-helper 17 response in humans

(2009) Lyudmila Lyakh et al.   IMMUNOLOGICAL REVIEWS

Tumor Microenvironments Direct the Recruitment and Expansion of Human Th17 Cells

(2009) X. Su et al.   JOURNAL OF IMMUNOLOGY

The prevalence of Th17 cells in patients with gastric cancer

(2008) Bin Zhang et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS